chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I WAS DIAGNOSED WITH CIDP ON 5/18/21. I RECEIVED FLU SHOT ON 9/20 STARTED WITH FEET AND LEG PAIN BY 10/20, SYMPTOMS GOT WORSE BY 12/20 I NOTICED NUMBNESS OF BIL TOES. GOT APPT WITH NEURO DOCTOR ON 1/14/21 SHE ORDERED BLOOD WORK, URINE AND EMG, PUT ME ON GABAPENTIN, EMG DONE ON 3/21, NEURO F/U VISIT 4/27 EMG WAS ABNORMAL, REST OF BLOOD WORK NORMAL, SHE ORDERED MRI OF THORACIC AND LUMBAR AND CHANGED GABAPENTIN FOR AMITRIPTYLINE BY THIS POINT SYMPTOMS WERE ON BIL HAND NUMBNESS AND WEAKNESS NOTED, MRI DONE 5/7/21 AND 5/18 F/U WITH NEURO AND SHE GAVE ME THE DX MRI COMPATIBLE WITH GBS CIPD AND PUT ME ON STEROIDS AND DRAW MORE BLOOD FOR ANTIBODIES. SHE ORDERED LUMBAR PUNCTURE AND WAS NORMAL, 5/24 TONGUE WAS NUMB AND WENT TO ER I WAS ADMITTED FOR 5 DAY AND START IVIG INFUSION 4 ROUNDS  DONE 5/19 IT CAME BACK NORMAL. SYMPTOMS GOT WORSE MORE
This spontaneous report as received from the office manager, refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported.  In approximately December 2014, reported as "2 years ago", the patient received a first dose of GARDASIL (dose, lot#, expiry date and route were not reported). On 19-DEC-2016, the patient received the second dose of GARDASIL (dose, lot#, expiry date and route were not reported). No adverse symptoms reported. Additional information has been requested.
Angioedema; Flu like symptoms; This spontaneous case was reported by an other health care professional and describes the occurrence of ANGIOEDEMA (Angioedema) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Dental operation (dental procedures in the last 6-12 months.) and Lip cosmetic procedure (Botox and Fillers). Concurrent medical conditions included Penicillin allergy and Drug allergy (Sulfa drugs.).   On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ANGIOEDEMA (Angioedema) (seriousness criterion medically significant) and INFLUENZA LIKE ILLNESS (Flu like symptoms). At the time of the report, ANGIOEDEMA (Angioedema) outcome was unknown and INFLUENZA LIKE ILLNESS (Flu like symptoms) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications information not reported. Treatment information not reported.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.   This case was linked to MOD-2021-268524 (Patient Link).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
episodes of facial and head numbness and heaviness, lasting 15-30 min or so; isolated to the side of injection site; episodes of facial and head numbness and heaviness, lasting 15-30 min or so; isolated to the side of injection site; This is a spontaneous report from a contactable physician. A 41-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot number: 0E51685), intramuscularly in the left arm, on 17Dec2020 at 09:00 (at the age of 41-years-old) at a single dose for COVID-19 immunization. The patient had no medical history. Concomitant medications, taken within two weeks of vaccination, included zinc (MANUFACTURER UNKNOWN), quercetin (MANUFACTURER UNKNOWN), and multivitamins (MANUFACTURER UNKNOWN). The patient was not pregnant at the time of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had no known allergies to medications, food, or other products. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient experienced episodes of facial and head numbness and heaviness, lasting 15-30 minutes or so; isolated to the side of injection site on 17Dec2020 at 22:15. No therapeutic measures were taken as a result of the events. The clinical outcome of episodes of facial and head numbness and heaviness, lasting 15-30 minutes or so; isolated to the side of injection site was not recovered. It was also reported that since the vaccination, the patient had not been tested for COVID-19.  No follow-up attempts are needed. No further information expected.
PER PATIENT GOT THE VACCINE ON 06/03/22 AT 09:31 AM, PATIENT LEFT FOR CITY THE NEXT DAY. ON 06/10/22 PATIENT FAINTED IN KITCHEN. PATIENT ALSO STATED HE WAS FEELING NOT GOOD AFTER VACCINE ('' UNEASY FEELING, TIRED ''). PATIENT WAS DISCHARED ON 06/12/22 FROM HOSPITAL. PER PATIENT HOSPITALIST TOLD HIM NEXT TIME FOR VACCINE HE WILL HAVE TO GO TO DOCTOR SO YHE CAN BE OBSERVED AFTER.
headache; blurred vision; couldn't stand without assistance; a band of numbness and tightness in my right arm that migrated down my arm from the site of the vaccination all the way to my wrist; a band of numbness and tightness in my right arm that migrated down my arm from the site of the vaccination all the way to my wrist; The site of injection also became very sore; a band of vice-like grip appeared around the lower part of my head, near my jaw, and it migrated up my head until it settled around my temples and eyes; faintness; strong vasovagal response; narrowing field of vision; rushing sound in ears; dizziness/severe dizziness; nausea; This is a spontaneous report from a contactable consumer (patient) reported for self. A 38-year-old female patient (not pregnant at time of vaccination) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 02Apr2021 at 16:30 (Lot number: EP7533) on the right arm at single dose for COVID-19 immunization. Medical history included chronic lyme disease, hypothyroidism, allergies to cephalosporin antibiotics. Concomitant medications included levothyroxine, metronidazole, sertraline, clonazepam (KLONOPIN); that all received within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient did not diagnosis with covid-19 and patient had not been tested for covid-19 since the vaccination. Patient experienced a strong vasovagal response within 30 seconds of receiving the dose with narrowing field of vision, rushing sound in ears, faintness, dizziness, nausea; all of these symptoms improved after lying on the floor for 15 minutes. 2 hours later, a band of vice-like grip appeared around the lower part of patient head, near patient jaw, and it migrated up patient head until it settled around patient temples and eyes. The patient developed a headache, blurred vision and severe dizziness such that he couldn't stand without assistance. Patient also felt a band of numbness and tightness in his right arm that migrated down his arm from the site of the vaccination all the way to his wrist. The site of injection also became very sore. There was no treatment received for the adverse events. The outcome of events was recovering.
This spontaneous report was received from a female patient of unknown age. On an unknown date the patient was vaccinated with a dose of pneumococcal vaccine, polyvalent (23-valent) (manufacturer unknown). No other co-suspects were reported. No concomitant medications were reported. The patient reported that she became very sick 48 hours after receiving pneumococcal vaccine, polyvalent (23-valent) (manufacturer unknown). She stated that she had both coughing and congestion. The patient had sought unspecified medical attention. The outcome of coughing and congestion was reported as recovered/resolved. Additional information has been requested.
swelling, tenderness and warmth at site of injection 1 week after injection.  24 hours after injection I had no swelling or pain.  My arm felt completely normal.  Then today I started getting hives on both arms and selling at the injection site with tenderness and it feels really warm to the touch.
It was reported that in a published abstract (2003), that a 6 y.o. female developed streptococcus pneumoniae meningitis and Specific Antibody Deficiency after being vax'd w/pneumococcal vax 23 polyvalent. The literature abstract is as follows: "We present a generally healthy 9 y.o. female who developed recurrent episodes of pneumococcal meningitis starting at age 5 9/12 yrs. In Nov. 98 she was hospitalized w/Streptococcus Pneumoniae meningitis. Past history revealed one episode of pneumonia at age 3 and moderately frequent otitis media infections. Labs included normal immunoglobulins and lymphocyte profile and negative sickle cell and HIV studies. After responding to antibiotics, she remained healthy for 10 mts but then developed Streptococcus viridans meningitis. Immunoglobulins, subclasses, and CH50 were normal. Despite having no documented history of trauma, a CSF leak was suspected and an occult fracture was confirmed by radiological imaging. Three attempts were made to repair the defect, but 5 add'l episodes of Streptococcus pneumoniae meningitis occurred over the next 2.5 yrs. "Pneumococcal vax 23 polyvalent" was given at age 6 7/12 after her 2nd meningitis episode. Pre-vax titers showed protection to only serotype 3. Post-vax titers were unchanged. A 2nd dose of "Pneumococcal vax 23 polyvalent" 3 mts later also failed to produce any response. Challenge w/"Streptococcus Pneumoniae vax" resulted in response to 4/6 serotypes. Titers to conjugated H. influenza and other protein antigens were normal. Specific Antibody Deficiency (SAD) is generally considered a maturational delay of the immune system and is an unusual isolated defect in an older child. Generally, response to conjugated vax would offer adequate protection, but the development of a CSF leak predisposed this otherwise minorly immunocompromised child to recurrent streptococcal meningitis. Currently, [a medical organization] is preventing further infections until a successful surgical repair can be accomplished." Upon internal review streptococcus pneumoniae meningitis and Specific Antibody Deficiency were determined to be other important medical events. (OMIC)
Got Covid after receiving Covid vaccines; Got Covid after receiving Covid vaccines; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient. A 75-year-old male patient received bnt162b2 (BNT162B2), on 18Mar2021 as dose 1, single (Lot number: ER2613), in left arm, on 07Apr2021 as dose 2, single (Lot number: EN6201) and on 11Oct2021 as dose 3 (booster), single (Lot number: BO155EA/30155EA) at the age of 73 years for covid-19 immunisation. The patient's relevant medical history included: "Vertigo cervical vertigo, positional vertigo" (unspecified if ongoing), notes: Vertigo cervical vertigo, positional vertigo; "venous chronic insufficiency" (unspecified if ongoing), notes: venous chronic insufficiency; "lesion in brainstem", start date: 2009 (unspecified if ongoing), notes: lesion in brainstem; "obese" (unspecified if ongoing); "migraines" (unspecified if ongoing); "anxiety" (unspecified if ongoing), notes: taking Soma, a muscle relaxer and Xanax for anxiety. Used since 1985, to manage stress migraines; "muscle relaxer", start date: 1985 (unspecified if ongoing), notes: taking Soma, a muscle relaxer and Xanax for anxiety. Used since 1985, to manage stress migraines; "back surgery" (unspecified if ongoing). Concomitant medication(s) included: SOMA CMPD taken for muscle relaxant therapy, start date: 1985; XANAX taken for anxiety, start date: 1985. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), outcome "unknown" and all described as "Got Covid after receiving Covid vaccines". Patient noted that he had sore throat and headache when he had Covid; he got Covid after receiving the Covid vaccines.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300327645 same patient/product, different dose number, different event;
Severe headache and fatigue.  Body ache and chills. Injection site was swollen and very sore.
I was getting my blood work done every 3 months and by the end of September my endocrinologist called me to tell me that my kidney function was declining and I had anemia and reduced red blood cells. At the beginning of November, on November 3rd, I got some blood work done and they called me to go to the emergency room, I was at the hospital for 3 weeks after this for kidney failure acute, anemia, and reduced red blood cells. They were trying to get my kidneys to start working again. They gave me steroids and 2 treatments of dialysis. I do not have the results of the medical tests done. I had 3 episodes after that. The next one was high potassium, I had to go to the emergency room and was admitted on December 12, 2022- December 14, 2022. The next time I had to go to the ER again was on December 18, 2022- December 23, 2022 for GI bleeding. I had 1/3 of my blood lost and I was passing out. And on April 16, 2023- April 24, 2023 I had to go back to the hospital because I had a rotavirus and C.DIFF. After these hospitalizations I had to take sodium citric acid solution 30 mL once a day, LOKELMA 1 packet daily, pantoprazole one tablet twice a day, sucralfate 1 tablet 4 times a day, iron ferrous sulfate 1 tablet twice a day, I did an IV infusion on February 28, 2023 and March 15, 2023, which destroys my immune system because they diagnosed me with IGG 4, Sjogren's syndrome, DBT, blood clot in left arm. I have been diagnosed with multiple things. They did multiple blood work tests during all my hospitalizations.
I had hives after 1st Pfizer dose. 2 days before 2nd dose scheduled (hives had resolved) I started to get itchy spots on right thigh. The day before 2nd dose I had watery blisters on right thigh in two spots. I went for 2nd dose and was advised that it may cause an even more adverse reaction and that I had 3 additional weeks to get 2nd dose if I didn't get it that day. I decided not to get it and do more research. I called PCP and got a call back next morning from NP I had spoken to earlier about hives. Advised not to take 2nd dose and wait regarding another type (eg J&J). I mentioned about the blisters but it was not addressed. I researched blisters and suspected I had Shingles even though I'd had Shingles vaccine some years prior. The next day pain was worse and more blisters appeared. I called insisting to speak with PCP, who diagnosed Shinlges over the phone and confirmed via photos I sent. Prescribed Valacyclovir. Four days after initial dose of Valacyclovi r Shngles symptoms beginning to subside.
severe upper arm pain for 4 days, fever of 101 for 1 day, feeling unwell for 2 days, headache for 4 days, chills and shaking sometimes for 1 day.
GAVE SHINGRIX FIRST - THEN FLUZONE QUAD ABOUT AN INCH DOWN FROM SHINGRIX - AS SOON AS I GAVE THE FLU SHOT PT STARTED TO BLEED AND AREA AROUND INJECTION SITE BEGAN TO SWELL AND BRUISE (ABOUT A QUARTER IN DIAMETER) - PT STATED THAT THE SHOT DID NOT HURT AND THE INJECTION SITE DID NOT HURT EITHER.  HAD PT SIT FOR 10 MINUTES AND MONITORED FOR DIFFICULTY BREATHING OR OTHER REACTIONS INCLUDING DIZZINESS - PTS REACTION DID NOT PROGRESS FURTHER AND PT STATED THEY WERE NOT DIZZY AND WERE NOT IN ANY PAIN - ADVISED PT TO LET DOCTOR KNOW AND MADE A NOTE IN PTS PROFILE - TOLD PT TO GIVE US A CALL IF ANYTHING CHANGES
Pt recvd flu vax & 6 days later pt was hospitalized for pancreatitis, hepatitis, & cholecystitis;
This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) and CHILLS (chills) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 03-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2 dosage. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, the patient experienced PYREXIA (Fever) and CHILLS (chills). On 05-Mar-2021, PYREXIA (Fever) and CHILLS (chills) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.
Approx 3 hours post administration: sore left shoulder (where shot given) Approx 11 hours post: swelling and red spot on arm, muscle soreness in arms and legs, shivering, 100.8 degree fever, unable to sleep Approx 19 hours post: fever broke, return to normal termperature, able to sleep 26 hours post: no issues except sore left arm with persisting swelling and red spot
Headache & Myalgia Narrative:  dose 1 day 1 sorearm/swelling;day 2 bruise/echymosis dose 2 day 1 arm pain; myalgia x2d; day 2 ha x 2 d; day 3 chills x 2 d; day 4 fatigue x 3 d
12/14/05 Mother stated baby had T 104 degrees for several days after 2 & 4 month shots.  10/5-05 Mother stated no problem with 1st immunization. On 10-14-05 mother state that child had fever after 2 mo (8-2-05) and 4 mo (10-5-05) immunizations. Unknown date of fever but mother stated baby had 104 degrees temp for severla days after both 2 and 4 mo shots.
devel soreness, redness @ inj site w/in 24hr;p/48hr pt devel n/v, diarrhea which lasted >12hr;soreness, redness, intestinal sx resolved p/72hr but a hard lump remains;
After receiving vaccine, patient began to complain of feeling dizzy. His vitals were checked and they were stable, but he was unable to stand without feeling like he was going to fall.  Patient was given food to see if that would help. He still continued to feel dizzy and was transported to see one of our doctors. The patients dizziness continued and he was unable to stand alone. Patient was moved to the ER for further work up.
Client was scheduled for his second vaccine of Pfizer when it was discovered in the immunization history that he had already received two doses of Pfizer on 01/14/2021 and 02/04/2021.  The client was transferred to Post-acute SNF after being hospitalized.  The charge nurse at the facility was made aware and there were no reported adverse reactions.
swelling of the upper arm up to the shoulder; he injection site began to itch profusely (terrible itching); intense redness on the arm; pain on her arm; soreness on the arm; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PERIPHERAL SWELLING (swelling of the upper arm up to the shoulder), VACCINATION SITE PRURITUS (he injection site began to itch profusely (terrible itching)), PAIN IN EXTREMITY (soreness on the arm), ERYTHEMA (intense redness on the arm) and HEADACHE (pain on her arm) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included METFORMIN, ATORVASTATIN CALCIUM (LIPITOR), MULTIVITAMIN & MINERAL, CYANOCOBALAMIN (B12 1000 SR), CALCIUM, MAGNESIUM and ZINC for an unknown indication.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, the patient experienced PAIN IN EXTREMITY (soreness on the arm). On 22-Jan-2021, the patient experienced PERIPHERAL SWELLING (swelling of the upper arm up to the shoulder), VACCINATION SITE PRURITUS (he injection site began to itch profusely (terrible itching)), ERYTHEMA (intense redness on the arm) and HEADACHE (pain on her arm). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE, PARACETAMOL, PHENYLEPHRINE HYDROCHLORIDE (BENADRYL ALLERGY & COLD) at a dose of 1 dosage form. At the time of the report, PERIPHERAL SWELLING (swelling of the upper arm up to the shoulder), VACCINATION SITE PRURITUS (he injection site began to itch profusely (terrible itching)), PAIN IN EXTREMITY (soreness on the arm), ERYTHEMA (intense redness on the arm) and HEADACHE (pain on her arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Vaccine exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination.     The patient's past medical history included Alcohol use from 24-Jan-2018 to 26-Nov-2020. Concurrent medical conditions included Allergy and Inflammation. Concomitant products included LEVOCABASTINE HYDROCHLORIDE (ZYRTEC [LEVOCABASTINE HYDROCHLORIDE]) from 01-Jan-2000 to an unknown date for Allergy, VITAMIN C [ASCORBIC ACID] from 01-Jan-2018 to an unknown date for Inflammation, MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) from 01-Jan-2018 to an unknown date for Pregnancy.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. The patient's last menstrual period was on 27-Oct-2020 and the estimated date of delivery was 23-Aug-2021. On 12-Mar-2021, the patient experienced EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  nineteenth week of the pregnancy.  On 12-Mar-2021, EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-Jan-2020, Ultrasound scan: normal (normal) normal with pregnancy confirmation at week 8. On 25-Nov-2020, Pregnancy test: positive (Positive) Positive. On 01-Jan-2021, Prenatal screening test: negative (Negative) For down syndrome and genetic deficiency..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information was not provided.
Shortly after vaccine was administered in right arm - right arm began hurting in area of injection. It has never stopped hurting. It hurts when the muscle is used in upper right arm and particular when right arm is raised
Patient's arm became warm, red, and swollen 12-24 hours after vaccination.  He reported the area of inflammation was about the size of a baseball at the worst point. About 60 hours after vaccination is when patient brought this to our attention so that we could report it, at that point patient's arm was red and only mildly swollen.  Patient reported feeling lethargic and having muscle aches all over his body, and that had subsided at about 60 hours post vaccination.